Paper31221981
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S and 2 others. Exp Mol Med, 2019. Cited by 201 papers, by iCite.
Cite this record
ConductScience Library. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Papers, record 31221981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31221981
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Neoplastic | Major topic |
| Histone Demethylases | Major topic |
| Isocitrate Dehydrogenase | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Histones | |
| Humans | |
| Nucleophosmin | |
| Tumor Hypoxia |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2016R1A2B4012840 | National Research Foundation of Korea (NRF) | International | PubMed | |
| 2018R1A4A1025985 | National Research Foundation of Korea (NRF) | International | PubMed | |
| 2016R1A2B4012840 | National Research Foundation of Korea (NRF) | International | PubMed | |
| 2018R1A4A1025985 | National Research Foundation of Korea (NRF) | International | PubMed | |
| 2016R1A2B4012840 | National Research Foundation of Korea (NRF) | International | PubMed | |
| 2018R1A4A1025985 | National Research Foundation of Korea (NRF) | International | PubMed |
Source PubMed
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22156295 | Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. | Genome Res | 2012 | https://conductscience.org/library/papers/22156295 | PubMed |
| 2 | 26212717 | Hypoxia Induces Production of L-2-Hydroxyglutarate. | Cell Metab | 2015 | https://conductscience.org/library/papers/26212717 | PubMed |
| 3 | 26729791 | H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis. | Cancer Res | 2016 | https://conductscience.org/library/papers/26729791 | PubMed |
| 4 | 22180306 | Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. | Oncologist | 2012 | https://conductscience.org/library/papers/22180306 | PubMed |
| 5 | 26190263 | The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential. | Cancer Cell | 2015 | https://conductscience.org/library/papers/26190263 | PubMed |
| 6 | 24561575 | Mitochondrial 2-hydroxyglutarate metabolism. | Mitochondrion | 2014 | https://conductscience.org/library/papers/24561575 | PubMed |
| 7 | 23152497 | Histone demethylase KDM6B promotes epithelial-mesenchymal transition. | J Biol Chem | 2012 | https://conductscience.org/library/papers/23152497 | PubMed |
| 8 | 26802933 | Histone H3K27 Demethylase JMJD3 in Cooperation with NF-κB Regulates Keratinocyte Wound Healing. | J Invest Dermatol | 2016 | https://conductscience.org/library/papers/26802933 | PubMed |
| 9 | 21828241 | Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. | Cancer Res | 2011 | https://conductscience.org/library/papers/21828241 | PubMed |
| 10 | 26645689 | Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26645689 | PubMed |
| 11 | 21998308 | Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21998308 | PubMed |
| 12 | 29533787 | Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29533787 | PubMed |
| 13 | 20142433 | Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. | J Exp Med | 2010 | https://conductscience.org/library/papers/20142433 | PubMed |
| 14 | 29625053 | Comprehensive Characterization of Cancer Driver Genes and Mutations. | Cell | 2018 | https://conductscience.org/library/papers/29625053 | PubMed |
| 15 | 26536169 | Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. | N Engl J Med | 2016 | https://conductscience.org/library/papers/26536169 | PubMed |
| 16 | 23764003 | Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. | Cancer Cell | 2013 | https://conductscience.org/library/papers/23764003 | PubMed |
| 17 | 26703470 | Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26703470 | PubMed |
| 18 | 29045832 | UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition. | Cell Rep | 2017 | https://conductscience.org/library/papers/29045832 | PubMed |
| 19 | 28332632 | Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. | Sci Rep | 2017 | https://conductscience.org/library/papers/28332632 | PubMed |
| 20 | 20371346 | A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. | Cell | 2010 | https://conductscience.org/library/papers/20371346 | PubMed |
Cited by155
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42918832 | FATP5 loss in hepatocellular carcinoma cells orchestrates tumor-promoting microenvironment by inducing passive long-chain fatty acid accumulation within tumor-associated endothelial cells. | Oncogene | 2026 | https://conductscience.org/library/papers/42918832 | PubMed |
| 42882896 | Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882896 | PubMed |
| 42807380 | Histone demethylase KDM4A promotes endometrial cancer progression through an ERRγ-associated cell-cycle regulatory axis. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42807380 | PubMed |
| 42756557 | Outcome of Acute Myeloid Leukemia Treatment and Isocitrate Dehydrogenase (IDH) Mutations: A Systematic Review and Meta-Analysis Study. | Int J Hematol Oncol Stem Cell Res | 2026 | https://conductscience.org/library/papers/42756557 | PubMed |
| 42723882 | Lipid metabolic reprogramming of tumor-associated macrophages drives resistance to immune checkpoint blockade in lung cancer: a narrative review of mechanisms and therapeutic strategies. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42723882 | PubMed |
| 42697963 | KDM6A loss enhances oxidative phosphorylation uncovering tissue-level convergent evolution. | EMBO J | 2026 | https://conductscience.org/library/papers/42697963 | PubMed |
| 42605498 | Germline predisposition and somatic mutational landscape in synchronous mucinous metaplasia and neoplasia of the female genital tract. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42605498 | PubMed |
| 42582931 | Epigenetics in lung cancer precision medicine: from bench to bedside-a narrative review. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42582931 | PubMed |
| 42529003 | The embedding of stress: mitophagy as a mechanism for the central nervous system (CNS) programming and lifelong disease vulnerability. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42529003 | PubMed |
| 42488672 | Mitochondrial reprogramming in cervical cancer: crosstalk with tumor immunity, HPV oncogenic signaling, and therapeutic resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488672 | PubMed |
| 42462028 | A transcriptional biosensor reveals mechanisms of α-ketoglutarate signaling to chromatin. | Science | 2026 | https://conductscience.org/library/papers/42462028 | PubMed |
| 42326014 | Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42326014 | PubMed |
| 42201147 | UTY (KDM6C) in Cancer: Epigenetic Regulation, Tumour Suppressor Functions, and Clinical Implications. | Epigenomes | 2026 | https://conductscience.org/library/papers/42201147 | PubMed |
| 42125691 | Progress in molecular markers associated with radiotherapy efficacy in glioma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42125691 | PubMed |
| 42077265 | Lysosomes contribute to the synthesis of tricarboxylic acid-related metabolites in the hippocampus. | Life Metab | 2026 | https://conductscience.org/library/papers/42077265 | PubMed |
| 41895442 | Fragile histidine triad (FHIT) suppresses gastric cancer via translational regulation of the epigenetic modifier KDM6B. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41895442 | PubMed |
| 41875824 | BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppression. | Neoplasia | 2026 | https://conductscience.org/library/papers/41875824 | PubMed |
| 41775697 | Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41775697 | PubMed |
| 41755769 | Hypoxia Preserves Chromatin Integrity and Delays Cellular Senescence through Epigenetic Regulation. | Biomol Ther (Seoul) | 2026 | https://conductscience.org/library/papers/41755769 | PubMed |
| 41543774 | Transcriptome and DNA methylation responses in the liver of Megalobrama amblycephala under hypoxia and heat stress. | Fish Physiol Biochem | 2026 | https://conductscience.org/library/papers/41543774 | PubMed |
Genes99
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31221981
GET https://conductscience.org/api/papers/v1/31221981/references?page=2